The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries

Many people see an effective preventive AIDS vaccine as the best solution to the HIV/AIDS pandemic. Ten years ago many scientists had hoped that a vaccine would be available by now. Most scientists are still optimistic that vaccines will be developed and many candidates are being tested. Strategies to implement HIV/AIDS vaccination need to be developed to be ready when vaccines do become available. The nature of those programs will depend on the characteristics of each vaccine.

Stover, Garnett, Seitz, and Forsythe use two computer simulation models to investigate the effects of various 
vaccine characteristics and implementation strategies on the impact and cost-effectiveness of vaccines in different contexts.